How the Euripid collaboration contributes to affordability of medicinal products

Autor: C Habl
Rok vydání: 2019
Předmět:
Zdroj: European Journal of Public Health. 29
ISSN: 1464-360X
1101-1262
DOI: 10.1093/eurpub/ckz186.402
Popis: Issue National authorities for pricing and reimbursement of medicinal products need up-to-date, easy accessible and unbiased information on the availability and prices of medicinal products in their fellow countries. Such information is needed for informed decision making, very often by countries who have an element of external price referencing (EPR) integrated into their national drug policy. EURIPID (www.euripid.eu) is a voluntary, non-profit collaboration between mainly European countries on building up and maintaining a database with information on national prices of medicinal products. It makes prices of price regulated medicinal products more transparent via an on-line accessible, comprehensive, reliable, and easy-to-use database. Challenges of the database are to bring the numerous products of the currently 28 countries to a common platform in a standardised format and to translate the products and their presentation into English language (especially those who have no centralised EMA marketing authorisation),to present four comparable price types (e.g., to which Danish price type does the British NHS price compare),to calculate or approximate missing price types,to provide additional information allowing to indicate the real price of the product rather than its list price. Results and lessons learned The participating countries agreed by online voting to share information on Managed Entry Agreements (or related arrangements) and provide volume information for the reimbursed products in the database. The countries also agreed to provide background information on the national pricing system. In the last EU period the Collaboration developed a Technical Guidance Document on External Price Referencing that regulates in 12 principles the “Do’s and Don’ts of ERP”. In the new grant period a stakeholder dialogue platform will be established to strengthening the cooperation within the EU in the field of pricing of medicinal products. Key messages The Euripid database is a valuable tool that is aiding countries to perform price comparisons for ERP or price monitoring for medicinal products in a standardised format. ERP is still widely used in Europe. The new activities of Euripid (e.g., a website offering information to the public), will contribute to a fair use of ERP and thus improve national decision making.
Databáze: OpenAIRE
Externí odkaz: